Showing: ◈ David Meek×
US, European, Japanese and Chinese patients could get novel medicines ahead of patients in the UK after Brexit, the CEO of French pharma Ipsen has said in an interview.
David Meek, the CEO of Ipsen, warns Britain leaving the European Union has seen the country fall down the list of priorities.